- Home
- ECBK vs AVR Comparison
ECBK vs AVR Comparison
Compare ECBK & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECBK
- AVR
- Stock Information
- Founded
- ECBK 1919
- AVR 1999
- Country
- ECBK United States
- AVR Australia
- Employees
- ECBK N/A
- AVR N/A
- Industry
- ECBK Banks
- AVR
- Sector
- ECBK Finance
- AVR
- Exchange
- ECBK Nasdaq
- AVR NYSE
- Market Cap
- ECBK 151.0M
- AVR 162.1M
- IPO Year
- ECBK N/A
- AVR 2024
- Fundamental
- Price
- ECBK $16.20
- AVR $3.17
- Analyst Decision
- ECBK
- AVR Strong Buy
- Analyst Count
- ECBK 0
- AVR 4
- Target Price
- ECBK N/A
- AVR $16.50
- AVG Volume (30 Days)
- ECBK 67.4K
- AVR 314.1K
- Earning Date
- ECBK 08-08-2025
- AVR 08-16-2025
- Dividend Yield
- ECBK N/A
- AVR N/A
- EPS Growth
- ECBK 17.87
- AVR N/A
- EPS
- ECBK 0.57
- AVR N/A
- Revenue
- ECBK $26,906,000.00
- AVR $2,493,000.00
- Revenue This Year
- ECBK N/A
- AVR $33.26
- Revenue Next Year
- ECBK N/A
- AVR $194.42
- P/E Ratio
- ECBK $28.23
- AVR N/A
- Revenue Growth
- ECBK 5.99
- AVR N/A
- 52 Week Low
- ECBK $12.50
- AVR $2.34
- 52 Week High
- ECBK $16.99
- AVR $8.79
- Technical
- Relative Strength Index (RSI)
- ECBK 59.34
- AVR N/A
- Support Level
- ECBK $15.81
- AVR N/A
- Resistance Level
- ECBK $16.45
- AVR N/A
- Average True Range (ATR)
- ECBK 0.40
- AVR 0.00
- MACD
- ECBK 0.11
- AVR 0.00
- Stochastic Oscillator
- ECBK 81.85
- AVR 0.00
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.